Astellas Pharma Inc  

(Public, TYO:4503)   Watch this stock  
Find more results for 4503
+1.50 (0.10%)
Mar 23 - Close
TYO data delayed by 20 mins - Disclaimer
Currency in JPY
Range 1,495.00 - 1,509.50
52 week 1,358.00 - 1,779.00
Open 1,507.00
Vol. 6.71M
Mkt cap 3.24T
P/E 15.37
Div/yield 17.00/2.19
EPS 97.93
Shares 2.09B
Beta     -
Inst. own     -
Jan 31, 2017
Q3 2017 Astellas Pharma Inc Earnings Release

Key stats and ratios

Q4 (Dec '16) 2016
Net profit margin 18.01% 14.11%
Operating margin 20.97% 18.11%
EBITD margin - 23.99%
Return on average assets 14.33% 10.78%
Return on average equity 20.12% 15.03%
Employees 17,217 -
CDP Score - 100 B


Astellas Pharma Inc. Headquarters 2-5-1, Nihombashihon-cho
CHUO-KU, TKY 103-8411
+81-3-32443000 (Phone)

Website links

External links


Astellas Pharma Inc. is a Japan-based company mainly engaged in the pharmaceutical business. The Company is involved in the manufacture and sale of pharmaceutical products in Japan, the United States, Europe, China, Korea and Taiwan, through its subsidiaries. Its main products include immunosuppressive drug Prograf, overactive bladder agent Vesicare, Protopic ointment for atopic dermatitis, Harnal for prostatic and urethral smooth muscle, and antimycotic agent Funguard, among others. It also provides pharmaceutical products for gastritis, osteoporosis, hypertension, schizophrenia, rheumatoid arthritis, atopic dermatitis and other diseases. The Company also engages in the research and development of ophthalmology pharmaceuticals through its subsidiaries.

Officers and directors

Yoshihiko Hatanaka President, Chief Executive Officer, Chairman of the Board of Directors, Representative Director
Age: 59
Yoshiro Miyokawa Vice President, Representative Director
Age: 64
Yasumasa Masuda Senior Executive Officer
Mitsunori Matsuda Senior Executive Officer, Chief Director of Pharmaceutical Technology
Makoto Takeuchi Senior Executive Officer, Director of External Affairs
Wataru Uchida Senior Executive Officer, Chief Director of Research
Kenji Yasukawa Senior Executive Officer, Chief Strategy Officer, Chief Commercial Officer
Chihiro Yokota Senior Executive Officer, Chief Director of Development
Nobuaki Tanaka Executive Officer, Chief Director of Sales
Fumiaki Sakurai Chief Administrative Officer, Chief Ethics & Compliance Officer, Executive Officer